AMNEAL ONCOLOGY PVT LTD

Direct Answer: Amneal Oncology Pvt Ltd is primarily a manufacturer.

Company Introduction:

Amneal Oncology Pvt Ltd is an Indian subsidiary of Amneal Pharmaceuticals, Inc., a global pharmaceutical company headquartered in the United States. It specializes in the development, manufacturing, and commercialization of high-quality oncology (cancer treatment) medications.

The company leverages the global expertise and research capabilities of its parent organization to bring innovative and affordable cancer therapies to the Indian market and beyond. Amneal Pharmaceuticals, including its operations in India, operates state-of-the-art manufacturing facilities that adhere to stringent international quality standards, such as those set by the US FDA (Food and Drug Administration) and other regulatory bodies.

Its core activities include active pharmaceutical ingredient (API) production, formulation development, and the manufacturing of finished dosage forms for various cancer indications. While it also engages in the marketing and distribution of its products, its fundamental identity and significant investment are in the production aspect. Therefore, it is categorized as a manufacturer with extensive research and development and production capabilities rather than solely a trading company.

Amneal Oncology Pvt. Ltd. (India) manufactures and/or markets the following products:

* Bendamustine

* Carboplatin

* Cisplatin

* Cyclophosphamide

* Dacarbazine

* Docetaxel

* Doxorubicin

* Epirubicin

* Etoposide

* Fluorouracil

* Gemcitabine

* Ifosfamide

* Irinotecan

* Mitomycin

* Oxaliplatin

* Paclitaxel

* Temozolomide

* Topotecan

* Vinblastine

* Vincristine

* Vinorelbine